Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways.

MLA

Yang, Miaoting, et al. “Hugan Qingzhi Tablets Attenuates Endoplasmic Reticulum Stress in Nonalcoholic Fatty Liver Disease Rats by Regulating PERK and ATF6 Pathways.” BMC Complementary Medicine and Therapies, vol. 24, no. 1, Jan. 2024, p. 36. EBSCOhost, https://doi.org/10.1186/s12906-024-04336-1.

APA

Yang, M., Yao, X., Xia, F., Xiang, S., Tang, W., & Zhou, B. (2024). Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways. BMC Complementary Medicine and Therapies, 24(1), 36. https://doi.org/10.1186/s12906-024-04336-1

Chicago

Yang, Miaoting, Xiaorui Yao, Fan Xia, Shijian Xiang, Waijiao Tang, and Benjie Zhou. 2024. “Hugan Qingzhi Tablets Attenuates Endoplasmic Reticulum Stress in Nonalcoholic Fatty Liver Disease Rats by Regulating PERK and ATF6 Pathways.” BMC Complementary Medicine and Therapies 24 (1): 36. doi:10.1186/s12906-024-04336-1.